Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Organic cation transporter preferentially expressed in hematopoietic cells and leukemias and uses thereof

Organic cation transporter preferentially expressed in hematopoietic cells and leukemias and uses thereof

US Patent 7723019 · Granted May 25, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AMP-activated protein kinase inhibitors and methods of making and using the same2025
Animal motion and temperature monitoring2024
STAT3 transcription factor inhibitors and methods of using the same2024
Animal motion and temperature monitoring2023
Data management systems and methods2022
Animal motion and temperature monitoring2021
Methods to impair hematologic cancer progenitor cells and compounds related ther2019
Triazole derivatives of melampomagnolide B and methods of use thereof2019
Use of parthenolide derivatives as antileukemic and cytotoxic agents2019
Melampomagnolide B dimers2018
Diagnostic methods for determining prognosis of non-small cell lung cancer2018
Melampomagnolide B dimers2018